Hannah Gardener Selected Research

Hannah Gardener Research Topics

Disease

21	Stroke (Strokes) 04/2022 - 12/2009
6	Hypertension (High Blood Pressure) 01/2016 - 07/2009
5	Ischemic Stroke 01/2022 - 01/2017
5	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 12/2009
5	Atherosclerosis 01/2018 - 12/2009
4	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2022 - 12/2009
4	Vascular Diseases (Vascular Disease) 11/2017 - 05/2012
4	Metabolic Syndrome (Dysmetabolic Syndrome X) 09/2014 - 06/2010
3	Obesity 01/2022 - 07/2009
3	Noma (Nomas) 02/2013 - 12/2009
2	Birth Weight (Birth Weights) 01/2021 - 08/2011
2	Carotid Artery Diseases 03/2018 - 06/2014
2	Heart Diseases (Heart Disease) 06/2014 - 09/2012
2	Insulin Resistance 02/2013 - 10/2010
1	Dyslipidemias (Dyslipidemia) 01/2022
1	Thrombosis (Thrombus) 01/2022
1	Arterial Occlusive Diseases (Arterial Occlusive Disease) 01/2022
1	Pathologic Constriction (Stenosis) 10/2021
1	Dysbiosis 03/2021
1	Cognitive Dysfunction 03/2021
1	Transient Ischemic Attack 01/2021
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2018
1	Vascular Remodeling 01/2018
1	Dementia (Dementias) 01/2017
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2017
1	Dry Eye Syndromes (Dry Eye Syndrome) 05/2014
1	Neoplasms (Cancer) 08/2013
1	Myocardial Infarction 02/2013
1	Peripheral Vascular Diseases (Peripheral Vascular Disease) 09/2012
1	Hypercholesterolemia 09/2012
1	Diabetes Mellitus 07/2012
1	Autistic Disorder (Autism) 08/2011
1	Sleep Wake Disorders 01/2011
1	Gestational Weight Gain 07/2009
1	Premature Birth (Birth, Premature) 07/2009
1	Overweight 07/2009

Drug/Important Bio-Agent (IBA)

8	Tissue Plasminogen Activator (Alteplase)FDA Link 04/2022 - 04/2015
7	Biomarkers (Surrogate Marker)IBA 01/2021 - 06/2010
3	oxidized low density lipoproteinIBA 01/2022 - 12/2009
3	LipidsIBA 01/2022 - 12/2009
3	AdiponectinIBA 02/2013 - 04/2012
2	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 10/2010
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 03/2021 - 01/2017
2	Dietary SodiumIBA 11/2017 - 05/2012
2	Receptor for Advanced Glycation End ProductsIBA 05/2015 - 09/2014
2	LDL CholesterolIBA 02/2013 - 07/2012
2	Proteins (Proteins, Gene)FDA Link 09/2012 - 12/2009
2	SodiumIBA 09/2012 - 05/2012
2	CholesterolIBA 06/2010 - 07/2009
1	LipopolysaccharidesIBA 03/2021
1	Lipopolysaccharide ReceptorsIBA 03/2021
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2019
1	Warfarin (Coumadin)FDA LinkGeneric 01/2019
1	ApolipoproteinsIBA 03/2018
1	Apolipoproteins E (ApoE)IBA 03/2018
1	Phenobarbital (Luminal)FDA Link 01/2018
1	PotassiumIBA 11/2017
1	SugarsIBA 01/2017
1	Antihypertensive Agents (Antihypertensives)IBA 01/2016
1	Vitamin D FDA LinkGeneric 05/2014
1	TeaIBA 08/2013
1	Coffee FDA Link 08/2013
1	AdipokinesIBA 02/2013
1	Triglycerides (Triacylglycerol)IBA 02/2013
1	HDL CholesterolIBA 02/2013
1	CarbohydratesIBA 09/2012
1	A 17 (A-17)IBA 05/2012
1	Blood Proteins (Serum Proteins)IBA 04/2012
1	Insulin (Novolin)FDA Link 04/2012
1	Apolipoproteins B (ApoB)IBA 12/2009
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 12/2009
1	HDL LipoproteinsIBA 12/2009
1	Blood Glucose (Blood Sugar)IBA 12/2009
1	SmokeIBA 07/2009
1	Diethylstilbestrol (Stilbestrol)FDA Link 07/2009

Therapy/Procedure

3	Therapeutics 01/2022 - 01/2017
2	Mediterranean Diet 01/2018 - 06/2014
1	Carotid Endarterectomy 10/2021
1	Catheters 10/2021
1	Patient Readmission 03/2021
1	Continuity of Patient Care 11/2020
1	Secondary Prevention 12/2019
1	Transitional Care 12/2019
1	Thrombolytic Therapy 10/2016
1	Aftercare (After-Treatment) 04/2015
1	Anesthesia 08/2011
1	Prenatal Care (Care, Prenatal) 07/2009